Prognostic value of routine blood biomarkers in 3-year survival of resectable colorectal cancer patients: a prognostic nomogram for clinical practice
Inflammatory biomarkers combined with clinical parameters robustly predict 3-year survival outcomes in CRC patients undergoing curative resection. These findings highlight the importance of systemic inflammation in CRC prognosis and support its inclusion in preoperative risk stratification.
Authors
- Vicente Pla‐Martí (ORCID: https://orcid.org/0000-0001-7644-8416)
- Stephanie García‐Botello (ORCID: https://orcid.org/0000-0001-6921-4902)
- Coral Cózar-Lozano
- José Martín‐Arévalo (ORCID: https://orcid.org/0000-0001-5337-9577)
- David Casado-Rodrigo
- Noelia Tarazona (ORCID: https://orcid.org/0000-0003-4888-1655)
- David Moro‐Valdezate (ORCID: https://orcid.org/0000-0003-0425-8677)
- Leticia Pérez‐Santiago (ORCID: https://orcid.org/0000-0002-3090-8330)
- Carolina Martínez‐Ciarpaglini (ORCID: https://orcid.org/0000-0002-8797-2114)
Institutions
- Universitat de València (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Clínico Universitario de Valencia (ES)
- INCLIVA Health Research Institute (ES)
- Centro de Investigación Biomédica en Red de Cáncer (ES)
Publication Details
- Journal
- International Journal of Colorectal Disease
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1007/s00384-025-04848-3
- Citations
- 6
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 6.27